Dr Laila Raman-Abdulla, an ophthalmologist, is urging residents to prioritise regular eye examinations this March as part of World Glaucoma Month. The global awareness campaign aims to educate the ...

Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the disease appear. Instead ...

A 40something woman was thought to be too young for glaucoma but more people below age 60 are being diagnosed with glaucoma ...

Glaucoma is likely to be treated when IOP reaches 22 mm Hg, but research shows that risk consistently increases even at lower IOP levels, according to a study published in JAMA Ophthalmology.“In ...

Explore the latest research on glaucoma treatment and the role of immune cells in eye pressure regulation for better outcomes ...

India carries a significant share of the global glaucoma burden. Approximately 12 million people or more live with this disease in India, which is one of the leading causes of blindness. But almost 90 ...

Artelo Biosciences (NASDAQ: ARTL) has announced its entry into the ophthalmology space with a fully funded clinical study evaluating ART27.13 in glaucoma patients. The investigator-sponsored trial ...

Store director Diana Kelly at Specsavers Linlithgow is one of just a handful of opticians across the country who have ...

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ...

A comanagement program at UCSF in which patients saw glaucoma-trained optometrists and had access to glaucoma specialists showed promising outcomes, according to a study published in Ophthalmology ...

Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.